Getmet Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 78.67%
- Ebitda 95.59%
- Net Worth -10.94%
- Total Assets -12.46%
About Getmet Pharma
Getmet Pharma Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 August 2016 (Eight years and five months 25 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tarun Goyal and Amit Goyal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999DL2016PTC305145
- Company No.
305145
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Getmet Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tarun Goyal  | Director | 07-Jun-2021 | Current |
| Amit Goyal | Director | 07-Jun-2021 | Current |
Financial Performance of Getmet Pharma.
Getmet Pharma Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 78.67% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Getmet Pharma?
In 2018, Getmet Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jas Professional Private LimitedAmit Goyal is a mutual person
Devince Couture Private LimitedTarun Goyal and Amit Goyal are mutual person
- Aa Ceramic World Private Limited
Tarun Goyal and Amit Goyal are mutual person
- Verge Mongers Private Limited
Tarun Goyal and Amit Goyal are mutual person
- Slg India Limited
Tarun Goyal and Amit Goyal are mutual person
- Slg Retail Private Limited
Tarun Goyal and Amit Goyal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Getmet Pharma?
Unlock and access historical data on people associated with Getmet Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Getmet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Getmet Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
